Calidi Biotherapeutics, Inc. (CLDI)
1.12
+0.02
(+1.82%)
USD |
NYAM |
Sep 21, 16:00
1.18
+0.06
(+5.36%)
After-Hours: 20:00
Calidi Biotherapeutics Shareholders Equity (Quarterly) : 3.133M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 3.133M |
| March 31, 2026 | 4.935M |
| December 31, 2025 | 3.759M |
| September 30, 2025 | 6.918M |
| June 30, 2025 | 1.764M |
| March 31, 2025 | 6.941M |
| December 31, 2024 | 1.534M |
| September 30, 2024 | -10.28M |
| June 30, 2024 | -11.75M |
| March 31, 2024 | -14.57M |
| December 31, 2023 | -8.235M |
| Date | Value |
|---|---|
| September 30, 2023 | -1.094M |
| June 30, 2023 | 31.24M |
| March 31, 2023 | 35.02M |
| December 31, 2022 | -40.84M |
| September 30, 2022 | 31.78M |
| June 30, 2022 | 220.94M |
| March 31, 2022 | 216.78M |
| December 31, 2021 | 215.32M |
| September 30, 2021 | 211.02M |
| June 30, 2021 | -0.0583M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.47M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.204M |
| Total Liabilities (Quarterly) | 4.071M |
| Debt to Equity Ratio | 0.6199 |
| Current Ratio | 1.677 |
| Net Debt Paydown Yield | 9.76% |